Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum

On September 16, 2025 Bristol Myers Squibb (NYSE: BMY) reported that the company will participate in the Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 (Press release, Bristol-Myers Squibb, SEP 16, 2025, View Source;2nd-Annual-Healthcare-Forum/default.aspx [SID1234655994]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will take part in a fireside chat beginning at 9:40 a.m. ET.

Investors and the general public are invited to listen to the session by visiting View Source An archived edition of the session will be available following its conclusion.